Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors

NCT00054977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Lung Cancer
Breast Cancer
Head and Neck Cancer
Prostate Cancer

Interventions

DRUG: GM-CT-01
DRUG: 5-fluorouracil

Sponsor

Galectin Therapeutics Inc.